Balyasny Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-46,993
| Closed | -$1.4M | – | 2076 |
|
|
2025
Q1 | $1.4M | Buy |
+46,993
| New | +$1.4M | ﹤0.01% | 1252 |
|
|
2024
Q1 | – | Sell |
-14,818
| Closed | -$456K | – | 2047 |
|
|
2023
Q4 | $456K | Buy |
+14,818
| New | +$456K | ﹤0.01% | 1462 |
|
|
2023
Q1 | – | Sell |
-167,816
| Closed | -$3.89M | – | 2262 |
|
|
2022
Q4 | $3.89M | Buy |
+167,816
| New | +$3.89M | 0.01% | 835 |
|
|
2020
Q1 | – | Sell |
-10,618
| Closed | -$219K | – | 1079 |
|
|
2019
Q4 | $219K | Buy |
+10,618
| New | +$219K | ﹤0.01% | 980 |
|
|
2018
Q4 | – | Sell |
-33,712
| Closed | -$497K | – | 1323 |
|
|
2018
Q3 | $497K | Buy |
+33,712
| New | +$497K | ﹤0.01% | 1163 |
|
|
2018
Q2 | – | Sell |
-17,520
| Closed | -$448K | – | 1630 |
|
|
2018
Q1 | $448K | Buy |
+17,520
| New | +$448K | ﹤0.01% | 1286 |
|